Open access
Sep 2026
Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV
Summary Respiratory viruses, such as SARS-CoV-2, remain a global medical challenge, highlighting the need for adaptable vaccine platforms that elicit broad immunity while allowing flexible antigen design. Building on our established envelope-deleted (ΔE) SARS-CoV-2 vaccine candidate, we engineered chimeric variants tha...
E. Kipfer, Jacob Schön, Mohamed Chami et al.
· iScience · 0 citations